Evaluation of the Disease Activity Score in Twenty‐Eight Joints–Based Flare Definitions in Rheumatoid Arthritis: Data From a Three‐Year Clinical Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|67|12|1762-1766

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.67, Iss.12, 2015-12, pp. : 1762-1766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 11, 2015-11 ,pp. : 2855-2860

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Modified Disease Activity Score Superior to the Disease Activity Score in Early Arthritis and Rheumatoid Arthritis? Comment on the Article by Baker et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3244-3245

John Wiley & Sons Inc

Access to resources Recommend Favorite

Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial

By  

Cardiology, Vol. 137, Iss. 4, 2017-04 ,pp. : 207-217

Karger

Access to resources Recommend Favorite

Contribution of the Subjective Components of the Disease Activity Score to the Response to Biologic Treatment in Rheumatoid Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 7, 2015-07 ,pp. : 923-928

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 12, 2015-12 ,pp. : 3104-3112

John Wiley & Sons Inc

Access to resources Recommend Favorite